TC
CRL icon

TownSquare Capital’s Charles River Laboratories CRL Stock Holding History

TownSquare Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,775
Closed -$1.92M – 799
2025
Q1 		$1.92M Buy
12,775
+10,229
+402% +$1.71M 0.02% 620
2024
Q4 		$470K Sell
2,546
-8,154
-76% -$1.57M 0.01% 1051
2024
Q3 		$2.11M Sell
10,700
-1,018
-9% -$212K 0.03% 538
2024
Q2 		$2.42M Sell
11,718
-282
-2% -$63.9K 0.03% 455
2024
Q1 		$3.25M Buy
12,000
+49
+0.4% +$11.7K 0.05% 340
2023
Q4 		$2.83M Sell
11,951
-285
-2% -$56K 0.05% 349
2023
Q3 		$2.4M Sell
12,236
-278
-2% -$57.1K 0.04% 359
2023
Q2 		$2.63M Buy
12,514
+1,715
+16% +$341K 0.05% 323
2023
Q1 		$2.18M Buy
10,799
+464
+4% +$105K 0.05% 310
2022
Q4 		$2.25M Buy
10,335
+969
+10% +$212K 0.06% 285
2022
Q3 		$1.84M Buy
9,366
+502
+6% +$108K 0.05% 274
2022
Q2 		$1.9M Buy
8,864
+416
+5% +$102K 0.05% 273
2022
Q1 		$2.4M Sell
8,448
-869
-9% -$268K 0.06% 250
2021
Q4 		$3.51M Sell
9,317
-1,022
-10% -$397K 0.09% 192
2021
Q3 		$4.27M Buy
10,339
+818
+9% +$340K 0.12% 151
2021
Q2 		$3.59M Buy
9,521
+1,894
+25% +$632K 0.12% 159
2021
Q1 		$2.21M Buy
7,627
+1,064
+16% +$296K 0.09% 195
2020
Q4 		$1.64M Buy
6,563
+980
+18% +$233K 0.07% 210
2020
Q3 		$1.3M Buy
5,583
+527
+10% +$109K 0.08% 199
2020
Q2 		$913K Buy
5,056
+210
+4% +$33.5K 0.06% 203
2020
Q1 		$672K Sell
4,846
-118
-2% -$17.7K 0.05% 227
2019
Q4 		$759K Buy
4,964
+280
+6% +$38.8K 0.06% 215
2019
Q3 		$597K Buy
4,684
+120
+3% +$16.1K 0.05% 266
2019
Q2 		$608K Sell
4,564
-439
-9% -$59.5K 0.06% 230
2019
Q1 		$727K Buy
5,003
+1,011
+25% +$133K 0.06% 215
2018
Q4 		$505K Buy
+3,992
New +$500K 0.07% 203

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

TownSquare Capital's CRL Position: Q2 2025 in Review

TownSquare Capital sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 12,775 shares — an estimated $1.92M sold.

TownSquare Capital first reported a position in CRL in Q4 2018 and held it in 26 quarters. The position peaked at $4.27M in Q3 2021. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • TownSquare Capital reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 12,775 Charles River Laboratories shares in Q2 2025, an estimated $1.92M.
  • TownSquare Capital first reported a position in Charles River Laboratories in Q4 2018 and held it in 26 quarters.
  • TownSquare Capital's Charles River Laboratories position peaked at $4.27M in Q3 2021.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.